Insulin receptor-sensitising polyaminosterols as a novel therapeutic approach for the treatment of type 2 diabetes

被引:0
|
作者
Govers, R. [1 ,2 ]
Gonzalez, T. [2 ]
Zaarour, N. [2 ]
Berenguer, M. [2 ]
Le Marchand-Brustel, Y. [3 ]
Tanti, J. -F. [3 ]
Bost, F. [3 ]
Corcelle, V. [3 ]
Zhang, J. [4 ]
Xu, T. [4 ]
Brunel, J. M. [5 ]
机构
[1] INRA, UMR 1260, INSERM, U1062, Marseille, France
[2] Fac Med Nice, INSERM, U895, F-06034 Nice, France
[3] Fac Med Nice, INSERM, U1065, F-06034 Nice, France
[4] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China
[5] CRCM, CNRS, UMR U7258, Marseille, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
606
引用
收藏
页码:S248 / S248
页数:1
相关论文
共 50 条
  • [1] Gene therapy with insulin receptor isoform a as an approach for the treatment of type 2 diabetes
    Diaz-Castroverde, S.
    Escribano, O.
    Luque, M.
    Gomez-Hernandez, A.
    Fernandez, S.
    Garcia-Gomez, G.
    Gonzalez-Aseguinolaza, G.
    Di Scala, M.
    Beneit, N.
    Perdomo, L.
    Benito, M.
    DIABETOLOGIA, 2015, 58 : S120 - S120
  • [2] Propagermanium as a Novel Therapeutic Approach for the Treatment of Endothelial Dysfunction in Type 2 Diabetes
    Azul, Lara
    Leandro, Adriana
    Seica, Raquel
    Sena, Cristina M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [3] Omentin: A novel therapeutic approach for the treatment of endothelial dysfunction in type 2 diabetes
    Leandro, Adriana
    Queiroz, Marcelo
    Azul, Lara
    Seica, Raquel
    Sena, Cristina M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 162 : 233 - 242
  • [4] Insulin secretion in type II diabetes - Therapeutic approach by novel nutrients
    Malaisse, WJ
    MOLECULAR AND CELL BIOLOGY OF TYPE 2 DIABETES AND ITS COMPLICATIONS, 1998, 14 : 1 - 13
  • [5] Novel therapeutic strategies for the treatment of type 2 diabetes
    Perfetti, R
    Barnett, PS
    Mathur, R
    Egan, JM
    DIABETES-METABOLISM REVIEWS, 1998, 14 (03): : 207 - 225
  • [6] Clinical manifestation of insulin resistance with type 2 diabetes: Surgical treatment as last therapeutic approach
    Marolt, I
    Gregoric, E
    DIABETES, 2004, 53 : A595 - A595
  • [7] Novel Clusters of Type 2 Diabetes: A Tailored Therapeutic Approach
    Duarte, Vitoria
    Ivo, Catarina
    Verissimo, David
    Silva, Joao
    Lopes, Luis
    Passos, Dolores
    de Castro, Joao Jacome
    Marcelino, Mafalda
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2020, 15 (3-4) : 109 - 113
  • [8] Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies
    Malek, R.
    Chong, A. Y.
    Lupsa, B. C.
    Lungu, A. O.
    Cochran, E. K.
    Soos, M. A.
    Semple, R. K.
    Balow, J. E.
    Gorden, P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08): : 3641 - 3647
  • [9] Bromocriptine - A novel approach to the treatment of type 2 diabetes
    Pijl, H
    Ohashi, S
    Matsuda, M
    Miyazaki, Y
    Mahankali, A
    Kumar, V
    Pipek, R
    Iozzo, P
    Lancaster, JL
    Cincotta, AH
    DeFronzo, RA
    DIABETES CARE, 2000, 23 (08) : 1154 - 1161
  • [10] Exenatide: A novel approach for treatment of type 2 diabetes
    Mikhail, Nasser
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (11) : 1271 - 1279